Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2576077 | The American Journal of Geriatric Pharmacotherapy | 2007 | 4 Pages |
Abstract
Caution should be exercised in prescribing DXM to geriatric patients, as they may be more susceptible to the drug's adverse effects because of increased clearance time. It appears that dose may play a greater role in causing psychosis, rather than the rate of metabolism, as evident in our patient who, contrary to the more oftendescribed scenario, was a slow metabolizer at CYP2D6.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
Nadia MD, Amit MD, Cheryl A. MD, Qin-Yue MD, PhD,